Current Indications for Photodynamic Therapy in Retina and Ocular Oncology

Purpose of Review The purpose of this review is to summarize the current indications for photodynamic therapy (PDT) in the treatment of retinal diseases and intraocular tumors. Recent Findings The recent introduction of new imaging modalities such as optical coherence tomography angiography and swept-source optical coherence tomography has enabled the quick and non-invasive identification of certain retinal conditions that benefit from PDT. Furthermore, recent reports in the literature have confirmed the role of PDT as an effective treatment modality for selected intraocular tumors. While the use of PDT has decreased since its introduction due to the advent of intravitreal anti-vascular endothelial growth factor therapy, there is still a role for this modality in several retinal conditions and intraocular tumors including central serous chorioretinopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy, choroidal neovascularization associated with choroidal nevus, choroidal hemangioma, choroidal metastasis, and retinal hemangioblastoma. PDT should be employed in the appropriate settings.

Automated summary

Photodynamic therapy (PDT) is now commonly used for the treatment of retinal diseases and intraocular tumors, particularly in the diagnosis and treatment of certain conditions.